ArticleOncotarget2016

Preparation study of indocyanine green-rituximab: A new receptor-targeted tracer for sentinel lymph node in breast cancer.

Bin-Bin Cong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.